Nephrocare Health Services vs Max Healthcare Institute
Side-by-side stock comparison based on AI earnings call analysis
Which stock has stronger management signals?
Nephrocare Health Services currently has the stronger revenue growth signal.
Nephrocare Health Services and Max Healthcare Institute show active capex signals based on earnings call analysis.
Max Healthcare Institute show fundraising activity or capital structure signals.
| Metric | Nephrocare Health Services | Max Healthcare Institute |
|---|---|---|
| Current Price | ₹624.3 | ₹884.75 |
| Market Cap | ₹6,277.89 Cr. | ₹86,113.62 Cr. |
| Industry | Healthcare Services | Healthcare Services |
| P/E Ratio | 73.76 | 60.63 |
| ROE (%) | 8.83 | 14.74 |
| Debt/Equity | 0.07 | 0.33 |
| Sales Growth 5Y (%) | 28.44 | 27.27 |
| Profit Growth 5Y (%) | 14.26 | -14.04 |
| Promoter Holding (%) | 58.32 | 23.71 |
| Revenue Rank | Rank 2 | Rank 3 |
| Margin Rank | Rank 3 | Rank 3 |
| Signal | — | — |
| Capex | Yes | Yes |
| Fundraise | No information | Yes |
Analyze Nephrocare Health Services →Analyze Max Healthcare Institute →Compare other stocks →Stock Screener →
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- Aster DM Quality Care LtdGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.